Pfizer CEO Albert Bourla won’t testify earlier than the European Parliament’s particular committee on COVID-19 later this month. The committee was anticipated to grill Bourla over the corporate’s secretive vaccine offers he struck with European Fee President Ursula von der Leyen. The deal preceeded the distribution of the Pfizer vaccine to Europe.
Different Massive Pharma corporations have already testified with the committee.
Von der Leyen was immediately concerned in preliminary negotiations for the EU’s greatest vaccine contract.
NEW – Pfizer CEO Bourla has pulled out of an appointment to testify earlier than the European Parliament’s particular committee.https://t.co/87S5sYSsXh
— Disclose.television (@disclosetv) October 1, 2022
TRENDING: LIVE STREAM VIDEO: President Trump Holds Save America Rally Tonight in Warren, Michigan – RSBN VIDEO
Politico reported:
Pfizer Chief Government Albert Bourla has pulled out of an appointment to testify earlier than the European Parliament’s particular committee on COVID-19, at which he was anticipated to face powerful questions on how secretive vaccine offers have been struck.
The choice follows an audit report into the EU’s vaccine procurement technique revealed earlier within the month that raised new questions on contact between Bourla and European Fee President Ursula von der Leyen that preceded a multibillion-euro vaccine contract.
The pinnacle of the U.S. pharmaceutical large, the most important provider of COVID-19 vaccines to the EU, was scheduled to seem earlier than the panel on October 10. The committee is assembly with key officers concerned within the EU’s vaccine procurement course of to attract classes on how to reply to future pandemics. Different pharmaceutical executives have addressed the committee, together with the CEO of Moderna and senior officers from AstraZeneca and Sanofi.
